AHFS July 2025 Update

This update contains 4 new monographs and 36 revised monographs.

New monographs: Antihemophilic Factor (Recombinant), Single Chain; Nipocalimab-aahu; Penpulimab-kcqx; Prademagene zamikeracel.

Revised monographs: Ambrisentan; Aprocitentan; ARIPiprazole; Asfotase Alfa; Atogepant; Axatilimab-csfr; Azithromycin (EENT); cloBAZam; Diclofenac; Dupilumab; Durvalumab; Erenumab-aooe; Filgrastim; Fremanezumab-vfrm; Galcanezumab-gnlm; Letermovir; Macitentan; Macitentan and Tadalafil; Mirikizumab-mrkz; Mirvetuximab soravtansine; Naltrexone; Nusinersen Sodium; Odevixibat; Omadacycline Tosylate; Patiromer Sorbitex Calcium; Pembrolizumab; Phenylephrine Hydrochloride (Systemic); Rimegepant Sulfate; Risdiplam; Seladelpar Lysine; Sotorasib; Sutimlimab-jome; Ubrogepant; Venlafaxine; Xanomeline and trospium chloride; Zavegepant Hydrochloride.